ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pain Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,589Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 97

$886K Total Retail Price of All Prescriptions

Rank: 3 out of 97

349 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 349 patients filled at least one prescription for a schedule two drug, compared to an average of 40%.

Schedule Three
Controlled Substances

24% of this provider’s 349 patients filled at least one prescription for a schedule three drug, compared to an average of 36%.

Risky Drugs to Seniors

1% of this provider’s 12,281 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 3%.

Brand Name Drugs

43% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$65 was the average price of a prescription from this provider, compared to $103 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
ZOLPIDEM TARTRATE 430 392 1 12
NEXIUM 411 381 2 29
CRESTOR 386 338 3 30
TRAMADOL HCL 372 337 4 10
HYDROCODONE-ACETAMINOPHEN 355 342 S3 5 1
ALENDRONATE SODIUM 322 312 6 28
MELOXICAM 316 275 7 15
VOLTAREN 308 286 8 22
DIOVAN HCT 308 295 8 36
OMEPRAZOLE 300 285 10 32
AMLODIPINE BESYLATE 264 250 11 38
SIMVASTATIN 258 231 12 34
CELEBREX 258 255 12 23
GABAPENTIN 250 212 14 2
METFORMIN HCL 236 201 15 39
TRIAMCINOLONE ACETONIDE 203 173 16 42
METOPROLOL TARTRATE 196 183 17 43
ATORVASTATIN CALCIUM 195 191 18 44
DIOVAN 190 178 19 45
LEVOTHYROXINE SODIUM 190 178 19 45
ALLOPURINOL 189 189 21 47
ATENOLOL 165 152 22 49
IBUPROFEN 164 114 23 24
FUROSEMIDE 162 149 24 41
DEXILANT 161 154 25 50
DONEPEZIL HCL 150 150 26 51
CARVEDILOL 136 133 27 56
LYRICA 130 125 28 13
PRAVASTATIN SODIUM 120 116 29 59
PANTOPRAZOLE SODIUM 117 92 30 48
AMLODIPINE BESYLATE-BENAZEPRIL 112 100 31 64
ADVAIR DISKUS 112 112 31 64
CLOPIDOGREL 111 104 33 67
LISINOPRIL 109 93 34 68
ACTOS 107 97 35 69
LOSARTAN-HYDROCHLOROTHIAZIDE 101 101 36 70
ESCITALOPRAM OXALATE 101 91 36 70
LIPITOR 100 98 38 72
GLIPIZIDE 91 66 39 74
METOPROLOL SUCCINATE 88 88 40 75
PLAVIX 83 78 41 78
LIDODERM 83 60 41 16
FAMOTIDINE 83 70 41 78
LOVAZA 77 77 44 80
POTASSIUM CHLORIDE 76 76 45 81
MECLIZINE HCL 75 75 46 82
IBANDRONATE SODIUM 73 73 47 53
SIMCOR 72 72 48 83
AZITHROMYCIN 72 65 48 83
CYMBALTA 70 62 50 19
SERTRALINE HCL 69 53 51 86
CLONIDINE HCL 68 47 52 58
ISOSORBIDE MONONITRATE ER 68 68 52 87
MEGESTROL ACETATE 68 68 R 52 87
JANUVIA 68 68 52 87
TAMSULOSIN HCL 66 54 56 92
PROAIR HFA 66 66 56 92
DETROL LA 65 65 58 94
WARFARIN SODIUM 63 63 59 95
PROCTOZONE-HC 60 47 60 97
RAMIPRIL 60 60 60 97
CLOTRIMAZOLE-BETAMETHASONE 60 60 60 97
PAROXETINE HCL 58 52 63 101
BONIVA 57 57 64 57
ZETIA 56 56 65 103
XOPENEX HFA 54 41 66 104
AVODART 54 54 66 104
ATELVIA 51 51 68 61
NIASPAN 51 51 68 110
BACLOFEN 51 36 68 18
ACTONEL 50 38 71 61
COLCRYS 50 50 71 112
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.